Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Expression, purification, and characterization of recombinant human factor X

A E Rudolph1, M P Mullane, R Porche-Sorbet

  • 1Department of Pathology, Washington University School of Medicine, St. Louis, Missouri 63110-8118, USA.

Protein Expression and Purification
|August 1, 1997
PubMed
Summary

This study developed a novel system for producing recombinant factor X using human kidney cells, yielding a product highly similar to plasma factor X. This advancement facilitates research into factor X structure-function relationships.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The longitudinal association of venue stability with consistent condom use among female sex workers in two Mexico-USA border cities.

International journal of STD & AIDS·2013
Same author

Perceptions of community- and family-level injection drug user (IDU)- and HIV-related stigma, disclosure decisions and experiences with layered stigma among HIV-positive IDUs in Vietnam.

AIDS care·2011
Same author

Adherence and persistence of single-pill ARB/CCB combination therapy compared to multiple-pill ARB/CCB regimens.

Current medical research and opinion·2010
Same author

A community-based approach to linking injection drug users with needed services through pharmacies: an evaluation of a pilot intervention in New York City.

AIDS education and prevention : official publication of the International Society for AIDS Education·2010
Same author

A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans.

Clinical pharmacology and therapeutics·2010
Same author

Effect of a selective aldosterone receptor antagonist in myocardial infarction.

American journal of physiology. Heart and circulatory physiology·2001

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Hematology

Background:

  • Factor X is a crucial protein in the blood coagulation cascade.
  • Existing methods for producing recombinant factor X have limitations.
  • Understanding factor X function is vital for treating bleeding disorders.

Purpose of the Study:

  • To develop an optimized system for producing functional recombinant factor X.
  • To compare the properties of recombinant factor X with human plasma factor X.
  • To establish a reliable method for recombinant factor X production for further research.

Main Methods:

  • Optimization of expression systems, comparing human kidney (293) cells and baby hamster kidney (BHK) cells.
  • Genetic modification of factor X for enhanced expression in 293 cells.

Related Experiment Videos

  • Purification using a calcium-dependent monoclonal antibody against the gla domain.
  • Functional characterization through activation assays and inhibition studies.
  • Main Results:

    • Human 293 cells are superior to BHK cells for functional factor X expression.
    • A specific residue substitution (Thr-->Arg) is required for propeptide removal.
    • Recombinant factor X exhibits comparable activation kinetics and enzymatic activity to plasma factor X.
    • Inhibition profiles by antithrombin and tissue factor pathway inhibitor are equivalent for both forms.

    Conclusions:

    • A robust system for producing high-quality recombinant factor X has been established.
    • The recombinant factor X produced is functionally equivalent to plasma-derived factor X.
    • This recombinant factor X is suitable for detailed structure-function studies using mutational analysis.